All News #Library
Rare Diseases
Paradigm Therapeutics Receives Investment to Develop SD-101
18 Jun 2025 //
PR NEWSWIRE
Paradigm gets Eshelman Funding for SD-101 Topical EB Treatment
06 May 2025 //
PR NEWSWIRE

Market Place
Sourcing Support